$GXI (+3.25%) Gerresheimer lowers growth forecast for 2024 and 2025 due to a significantly slower than expected market recovery in 2024 and lower than expected market growth in 2025 in the injection vials market.
The figures for the third quarter will be published on 10.10.24.
https://www.wallstreet-online.de/nachricht/18543557-gerresheimer-ag-wachstumsprognose-2024-2025
